ASND Ascendis Pharma ADRs

Ascendis Pharma A/S is a biotechnology company that applies its TransCon technology to develop a pipeline of prodrug therapies with profiles that address markets with unmet medical needs. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$105.39  -0.16 (-0.15%)
As of 03/23/2023 15:48:40 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Denmark
Country of incorporation:  
IPO date:  01/28/2015
Outstanding shares:  57,027,240
Average volume:  220,206
Market cap:   $6,507,948,629
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      BV9G6B8

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%